Previous Article | Next Article 
Journal of Clinical Microbiology, February 2000, p. 883-885, Vol. 38, No. 2
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Presence of Type III Secretion Genes in
Burkholderia pseudomallei Correlates with
Ara
Phenotypes
Craig
Winstanley* and
C. Anthony
Hart
Department of Medical Microbiology and
Genito-Urinary Medicine, University of Liverpool, Liverpool L69
3GA, United Kingdom
Received 29 July 1999/Returned for modification 17 September
1999/Accepted 1 November 1999
 |
ABSTRACT |
Dot blot hybridization and PCR amplification of 14 Ara+
and 8 Ara
Burkholderia pseudomallei strains
showed that type III secretion (TTS) genes were present in all the
Ara
strains but absent from all but one of the
Ara+ strains. The link between TTS genes and an
Ara
phenotype suggests a role for TTS in virulence.
 |
TEXT |
Burkholderia pseudomallei
is the causative agent of melioidosis, an often fatal infection endemic
to areas of Southeast Asia and Australia (6). Two varieties
of B. pseudomallei strains have been identified. One, the
species isolated from all clinical infections and some environments, is
unable to utilize arabinose (Ara
). The second variety,
which has only been found in the environment, is arabinose positive
(Ara+). Smith et al. (10) reported that
Ara+ B. pseudomallei is avirulent in mice, which
has led to the suggestion that a new species designation,
Burkholderia thailandensis, should be used to identify those
strains differing from melioidosis-causing so-called "true"
B. pseudomallei (2). In a previous study, we
found that flagellin gene variation occurs between the two biotypes
(13). Dharakul et al. (3) used a multiplex PCR
approach based on 16S rRNA genes to discriminate between the two
biotypes but reported that the sequence differences were insufficient
to merit classification into a new species. Whatever the merits of subdivision into two species, the specific factors determining the
greater virulence of the B. pseudomallei Ara
biotype remain to be resolved.
The current state of knowledge regarding the pathogenicity of B. pseudomallei was the subject of a recent review by Woods et al.
(15). Although some potential virulence factors, including a
number of secreted products, such as protease, haemolysin, lipase, and
lecithinase, have been identified (1, 9), much remains to be
learned about B. pseudomallei pathogenicity. In a number of
gram-negative bacteria, type III secretion (TTS) system pathogenicity islands, involved in delivering virulence factors directly to host
cells, have been shown to play crucial roles in pathogenicity (5,
7). By using TTS genes from the plant pathogen Ralstonia solanacearum (11) as a probe, we recently identified,
in B. pseudomallei, a cluster of putative genes homologous
to those encoding HpaP, HrcQ (HrpQ), HrcR (HrpT), HrcS (HrpU), and HrpV of the R. solanacearum TTS system (14). Under the
unified nomenclature proposed by Hueck (5), three of the
B. pseudomallei predicted proteins have been designated SctQ
(HrcQ homolog), SctR (HrcR homolog), and SctS (HrcS homolog). Because
they lack homologs in the majority of TTS systems reported to date, the
HpaP and HrpV homologs are not included in the unified nomenclature.
This study reports a link between the presence of putative TTS system genes and the Ara
phenotype, the more virulent biotype of
B. pseudomallei.
B. pseudomallei and other strains used in this study are
listed in Table 1. B. pseudomallei strains were maintained on blood agar. Other strains
were maintained on nutrient agar. Genomic DNA was extracted from
B. pseudomallei following growth on blood agar medium. Using
a sterile inoculating loop, a thick bacterial suspension was made in
0.5 ml of a solution containing lysozyme (1.5 mg ml
1),
sucrose (100 mg ml
1), and heat-treated RNase A (0.5 mg
ml
1) and left at room temperature for 20 min. After the
addition of 0.5 ml of TES buffer (10 mM Tris, 1 mM EDTA, 0.05 M NaCl
[pH 8.0]) and 0.25 ml of sodium lauroyl sarcosine (24 mg
ml
1 in TES buffer), the mixture was vortexed for 3 min.
The preparation was then subjected to CsCl-ethidium bromide
centrifugation and DNA band extraction by established procedures.
Genomic DNA was extracted from other bacterial strains by a similar
procedure, with the exception that the initial suspension was made
following the harvesting of 3 ml of overnight nutrient broth culture.
Oligonucleotide primers (forward primer BPTTSF
[5'-CTTCAATCTGCTCTTTCCGTT-3'] and reverse primer BPTTSR
[5'-CAGGACGGTTTCGGACGAA-3']) obtained from Genosys for PCR
amplification were designed to amplify a 548-bp region of the B. pseudomallei TTS gene cluster (GenBank AF074878, positions 3934 to
4481), encompassing part of open reading frame 2 (ORF2) and the
putative gene downstream of ORF2 (homologous to R. solanacearum
hrpV and hrpW, respectively [14]). Genomic DNA (2.5 µl) was used directly in 25-µl volumes containing 2 U of Dynazyme (Flowgen Instruments Ltd., Sittingbourne, Kent, United
Kingdom), 200 nM concentrations of each primer (BS7 and BS8), 1×
Dynazyme buffer, and 100 µM concentrations of nucleotides dATP, dCTP,
dGTP, and dTTP. Amplifications were carried out in an OmniGene thermal
cycler (Hybaid Ltd., Ashford, Middlesex, United Kingdom) for 30 cycles
consisting of 95°C (1 min), 60°C (1 min), and 72°C (2 min), with
an additional extension time at 72°C (10 min) following completion of
the 30 cycles. At the end of the amplification, 5-µl samples were
subjected to electrophoresis on a standard 1.0% (wt/vol) agarose gel
to confirm the presence of an amplified product.
In order to carry out dot blot hybridization of genomic DNA, a total
volume of 5 µl of genomic DNA (approximately 0.25 µg) was subjected
to vortexing for 2 min prior to the addition of 0.5 µl of 1 M NaOH.
Denatured DNA was dotted directly onto a dry Hybond-N membrane
(Amersham Pharmacia Biotech). The membrane was washed briefly in 4×
SSC (20× SSC is 3 M NaCl plus 0.3 M trisodium citrate [pH 7.0])
followed by 0.5× SSC, allowed to dry, baked for 2 h at 80°C,
and used directly in a hybridization experiment. The 548-bp amplified
product was labeled with digoxigenin-11-2'-dUTP (DIG) (Boehringer
Mannheim) by PCR amplification with DNA from a cosmid clone containing
the putative TTS system genes of B. pseudomallei
(14) as a template. The reaction conditions were as
described earlier, with the exception that 60 µM DIG was included. After overnight hybridization at 68°C, blots were washed at 68°C successively in 6× SSC, 0.1% sodium dodecyl sulfate (SDS) (twice for
15 min), 2× SSC, 0.1% SDS (twice for 15 min), 0.2× SSC, 0.1% SDS
(twice for 15 min), and 0.1× SSC-0.1% SDS (twice for 5 min). The
presence of DIG on dot blots was detected by using anti-DIG-alkaline phosphatase Fab fragments and the chemiluminescent substrate CDP-Star (Boehringer Mannheim) in the procedure recommended by the supplier. DNA
from a cosmid clone containing the putative TTS system genes of
B. pseudomallei (14) was included on the filter
as a strong positive control.
PCR amplification of TTS-associated DNA suggested a link between the
presence of TTS genes and the Ara
phenotype (Fig.
1). This link was further confirmed by
dot blot hybridization, which indicated that while B. pseudomallei Ara
strains all hybridized with the TTS
probe, B. pseudomallei Ara+ strains did not
(Fig. 2). The exception to this rule was
the Ara+ strain E27, which proved positive for TTS genes by
both PCR and hybridization (Fig. 1 and 2). There was no hybridization
with DNA from any of the other representatives of the
-subdivision proteobacteria, including R. solanacearum, which is known to
contain a TTS system. This is probably due to the low levels of
homology between R. solanacearum hrpV and hrpW
and their equivalent B. pseudomallei genes. It has been
observed in a number of bacteria that while many of the genes in
individual TTS systems encode proteins with homologs in other TTS
systems, a particular system may contain genes not widely observed in
other TTS systems and even unique to itself. In addition, the extent of
homology between equivalent genes varies (5). Thus, our
observations do not preclude the possibility that TTS systems exist in
Burkholderia cepacia. A TTS system has already been reported
in Bordetella bronchiseptica (16). Our choice of
probe in this study was intended to target regions likely to have less
homology with other TTS systems in order to circumvent any difficulties
due to the fact that many of the best-conserved TTS system proteins
have equivalent homologs in the flagellar apparatus.

View larger version (62K):
[in this window]
[in a new window]
|
FIG. 1.
PCR amplification of B. pseudomallei TTS DNA.
The figure shows an agarose gel of two rows of PCR amplification
products derived from B. pseudomallei strains. The upper row
samples are from B. pseudomallei strains 204 (lane 1), E27
(lane 2), 576 (lane 3), E25 (lane 4), E82 (lane 5), E8 (lane 6), E503
(lane 7), E504 (lane 8), E505 (lane 9), E506 (lane 10), E32 (lane 11),
and E111 (lane 12). The lower row samples are from B. pseudomallei strains E125 (lane 1), E132 (lane 2), E135 (lane 3),
E202 (lane 4), E216 (lane 5), E251 (lane 6), E253 (lane 7), E254 (lane
8), E255 (lane 9), and E260 (lane 10) and B. cepacia E241
(lane 11). Lane 12 of lower row, empty. Lane M, PCR size marker
(fragment sizes of 2,000, 1,500, 1,000, 750, 500, 300, 150, and 50 bp;
R&D Systems, Abingdon, Oxfordshire, United Kingdom).
|
|

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 2.
Dot blot hybridization of B. pseudomallei
Ara+ and Ara genomic DNA. Except as noted,
the blot contains genomic DNA from B. pseudomallei strains,
as follows: in row A, 204 (Ara ) (lane 1), E27
(Ara+) (lane 2), 576 (Ara ) (lane 3), E25
(Ara ) (lane 4), E82 (Ara+) (lane 5), and E8
(Ara ) (lane 6); in row B, E503 (Ara ) (lane
1), E504 (Ara ) (lane 2), E505 (Ara ) (lane
3), E506 (Ara ) (lane 4), E32 (Ara+) (lane 5),
and E111 (Ara+) (lane 6); in row C, E125 (Ara+)
(lane 1), E132 (Ara+) (lane 2), E135 (Ara+)
(lane 3), E202 (Ara+) (lane 4), E216 (Ara+)
(lane 5), and E251 (Ara+) (lane 6); in row D, E253
(Ara+) (lane 1), E254 (Ara+) (lane 2), E255
(Ara+) (lane 3), and E260 (Ara+) (lane 4), as
well as B. cepacia E241 (lane 5) and B. bronchiseptica SB22 (lane 6); and in row E, cosmid clone
containing B. pseudomallei TTS gene cluster (lane 1),
Neisseria meningitidis C311 (lane 2), and R. solanacearum GMI1000 (lane 3). Lanes 4, 5, and 6 of row E are
empty.
|
|
PCR screening using oligonucleotide primers BPTTSF and BPTTSR provides
a rapid means of identifying B. pseudomallei strains containing TTS genes. The link between an Ara
phenotype
and the presence of TTS genes suggests that TTS may play a role in the
greater virulence associated with Ara
B. pseudomallei strains. However, one Ara+ strain, E27,
proved to be an exception. This strain can be distinguished from
Ara
isolates by its ability to assimilate arabinose and
by virtue of a different flagellin gene sequence (13). When
analyzed using the multiplex PCR procedure of Dharakul et al.
(3), E27 yields the single amplicon indicative of an
Ara+ phenotype (our unpublished observation). It is
possible that E27 is more virulent than is generally the case for an
Ara+ strain. Alternatively, the strain may not contain a
complete and functional TTS system gene cluster. Only when the TTS
system of B. pseudomallei is fully characterized and the
secreted proteins have been identified will it be possible to resolve
the apparent anomaly of TTS-associated DNA in E27. The presence of TTS
genes in all of the Ara
isolates tested does suggest a
link between these genes and virulence in B. pseudomallei,
but much work remains to be done before the contribution of TTS to the
pathogenesis of this organism is understood.
 |
ACKNOWLEDGMENTS |
We thank T. Pitt, Public Health Laboratory Service, London, United
Kingdom, for providing strains.
 |
FOOTNOTES |
*
Corresponding author. Department of Medical
Microbiology and Genito-Urinary Medicine, University of Liverpool, P.O.
Box 147, Liverpool L69 3BX, United Kingdom. Phone: 44 (0)151 706 2000, ext. 4388. Fax: 44 (0)151 706 5805. E-mail:
C.Winstanley{at}liverpool.ac.uk.
 |
REFERENCES |
| 1.
|
Ashdown, L. R., and J. M. Koehler.
1990.
Production of hemolysin and other extracellular enzymes by clinical isolates of Pseudomonas pseudomallei.
J. Clin. Microbiol.
28:2331-2334[Abstract/Free Full Text].
|
| 2.
|
Brett, P. J.,
D. DeShazer, and D. E. Woods.
1998.
Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species.
Int. J. Syst. Bacteriol.
48:317-320[Abstract/Free Full Text].
|
| 3.
|
Dharakul, T.,
B. Tassaneetrithep,
S. Trakulsomboon, and S. Songsivilai.
1999.
Phylogenetic analysis of Ara+ and Ara Burkholderia pseudomallei isolates and development of a multiplex PCR procedure for rapid discrimination between the two biotypes.
J. Clin. Microbiol.
37:1906-1912[Abstract/Free Full Text].
|
| 4.
|
Hales, B. A.,
J. A. W. Morgan,
C. A. Hart, and C. Winstanley.
1998.
Variation in the flagellin genes and proteins of Burkholderia cepacia.
J. Bacteriol.
180:1110-1118[Abstract/Free Full Text].
|
| 5.
|
Hueck, C. J.
1998.
Type III protein secretion systems in bacterial pathogens of animals and plants.
Microbiol. Mol. Biol. Rev.
62:379-433[Abstract/Free Full Text].
|
| 6.
|
Leelarasmee, A., and S. Bovornkitti.
1989.
Melioidosis: review and update.
Rev. Infect. Dis.
11:413-425[Medline].
|
| 7.
|
Mecsas, J., and E. J. Strauss.
1996.
Molecular mechanisms of bacterial virulence: type III secretion and pathogenicity islands.
Emerg. Infect. Dis.
2:271-288.
|
| 8.
|
Perry, A. C. F.,
C. A. Hart,
I. J. Nicholson,
J. E. Heckels, and J. R. Saunders.
1987.
Inter-strain homology of pilin gene sequences in Neisseria meningitidis isolates that express markedly different antigenic pilin types.
J. Gen. Microbiol.
133:1409-1418[Medline].
|
| 9.
|
Sexton, M. M.,
A. L. Jones,
W. Chaowagul, and D. E. Woods.
1994.
Purification and characterisation of a protease from Pseudomonas pseudomallei.
Can. J. Microbiol.
40:903-910[Medline].
|
| 10.
|
Smith, M. D.,
B. J. Angus,
V. Wuthiekanun, and N. J. White.
1997.
Arabinose assimilation defines a nonvirulent biotype of Burkholderia pseudomallei.
Infect. Immun.
65:4319-4321[Abstract].
|
| 11.
|
Van Gijsegem, F.,
C. Gough,
C. Zischek,
E. Niqueux,
M Arlat,
S. Genin,
P. Barberis, and S. German.
1995.
The hrp locus of Pseudomonas solanacearum, which controls the production of a type III secretion system, encodes eight proteins related to components of the bacterial flagellar biogenesis complex.
Mol. Microbiol.
15:1095-1114[CrossRef][Medline].
|
| 12.
|
Willoughby, K.,
S. Dawson,
R. C. Jones,
M. Symons,
J. Daykin,
C. Payne-Johnson,
R. M. Gaskell,
M. Bennett, and C. J. Gaskell.
1991.
Isolation of Bordetella bronchiseptica from kittens with pneumonia in a breeding cattery.
Vet. Rec.
129:407-408[Medline].
|
| 13.
|
Winstanley, C.,
B. A. Hales,
J. E. Corkill,
M. J. Gallagher, and C. A. Hart.
1998.
Flagellin gene variation between clinical and environmental isolates of Burkholderia pseudomallei contrasts with the invariance among clinical isolates.
J. Med. Microbiol.
47:689-694[Abstract].
|
| 14.
|
Winstanley, C.,
B. A. Hales, and C. A. Hart.
1999.
Evidence for the presence in Burkholderia pseudomallei of a type III secretion system-associated gene cluster.
J. Med. Microbiol.
48:649-656[Abstract].
|
| 15.
|
Woods, D. E.,
D. DeShazer,
R. A. Moore,
P. J. Brett,
M. N. Burtnick,
S. L. Reckseidler, and M. D. Senkiw.
1999.
Current studies on the pathogenesis of melioidosis.
Microbes Infect.
2:157-162.
|
| 16.
|
Yuk, M. H.,
E. T. Harvill, and J. F. Miller.
1998.
The BvgAS virulence control system regulates type III secretion in Bordetella bronchiseptica.
Mol. Microbiol.
28:945-959[CrossRef][Medline].
|
Journal of Clinical Microbiology, February 2000, p. 883-885, Vol. 38, No. 2
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Kaestli, M., Mayo, M., Harrington, G., Watt, F., Hill, J., Gal, D., Currie, B. J.
(2007). Sensitive and Specific Molecular Detection of Burkholderia pseudomallei, the Causative Agent of Melioidosis, in the Soil of Tropical Northern Australia. Appl. Environ. Microbiol.
73: 6891-6897
[Abstract]
[Full Text]
-
Smart, C. H. M., Scott, F. W., Wright, E. A., Walshaw, M. J., Hart, C. A., Pitt, T. L., Winstanley, C.
(2006). Development of a diagnostic test for the Midlands 1 cystic fibrosis epidemic strain of Pseudomonas aeruginosa.. J Med Microbiol
55: 1085-1091
[Abstract]
[Full Text]
-
Smart, C. H. M., Walshaw, M. J., Hart, C. A., Winstanley, C.
(2006). Use of suppression subtractive hybridization to examine the accessory genome of the Liverpool cystic fibrosis epidemic strain of Pseudomonas aeruginosa. J Med Microbiol
55: 677-688
[Abstract]
[Full Text]
-
Duangsonk, K., Gal, D., Mayo, M., Hart, C. A., Currie, B. J., Winstanley, C.
(2006). Use of a Variable Amplicon Typing Scheme Reveals Considerable Variation in the Accessory Genomes of Isolates of Burkholderia pseudomallei. J. Clin. Microbiol.
44: 1323-1334
[Abstract]
[Full Text]
-
Novak, R. T., Glass, M. B., Gee, J. E., Gal, D., Mayo, M. J., Currie, B. J., Wilkins, P. P.
(2006). Development and Evaluation of a Real-Time PCR Assay Targeting the Type III Secretion System of Burkholderia pseudomallei. J. Clin. Microbiol.
44: 85-90
[Abstract]
[Full Text]
-
GAL, D., MAYO, M., SPENCER, E., CHENG, A. C., CURRIE, B. J.
(2005). APPLICATION OF A POLYMERASE CHAIN REACTION TO DETECT BURKHOLDERIA PSEUDOMALLEI IN CLINICAL SPECIMENS FROM PATIENTS WITH SUSPECTED MELIOIDOSIS. Am J Trop Med Hyg
73: 1162-1164
[Abstract]
[Full Text]
-
Bernier, S. P., Sokol, P. A.
(2005). Use of Suppression-Subtractive Hybridization To Identify Genes in the Burkholderia cepacia Complex That Are Unique to Burkholderia cenocepacia. J. Bacteriol.
187: 5278-5291
[Abstract]
[Full Text]
-
Thibault, F. M., Valade, E., Vidal, D. R.
(2004). Identification and Discrimination of Burkholderia pseudomallei, B. mallei, and B. thailandensis by Real-Time PCR Targeting Type III Secretion System Genes. J. Clin. Microbiol.
42: 5871-5874
[Abstract]
[Full Text]
-
Chacon, M. R., Soler, L., Groisman, E. A., Guarro, J., Figueras, M. J.
(2004). Type III Secretion System Genes in Clinical Aeromonas Isolates. J. Clin. Microbiol.
42: 1285-1287
[Abstract]
[Full Text]
-
Ulrich, R. L., DeShazer, D.
(2004). Type III Secretion: a Virulence Factor Delivery System Essential for the Pathogenicity of Burkholderia mallei. Infect. Immun.
72: 1150-1154
[Abstract]
[Full Text]
-
Smith-Vaughan, H. C., Gal, D., Lawrie, P. M., Winstanley, C., Sriprakash, K. S., Currie, B. J.
(2003). Ubiquity of Putative Type III Secretion Genes among Clinical and Environmental Burkholderia pseudomallei Isolates in Northern Australia. J. Clin. Microbiol.
41: 883-885
[Abstract]
[Full Text]
-
Parsons, Y. N., Panagea, S., Smart, C. H. M., Walshaw, M. J., Hart, C. A., Winstanley, C.
(2002). Use of Subtractive Hybridization To Identify a Diagnostic Probe for a Cystic Fibrosis Epidemic Strain of Pseudomonas aeruginosa. J. Clin. Microbiol.
40: 4607-4611
[Abstract]
[Full Text]
-
WINSTANLEY, C.
(2002). Spot the difference: applications of subtractive hybridisation to the study of bacterial pathogens. J Med Microbiol
51: 459-467
[Abstract]
[Full Text]
-
RAINBOW, L., HART, C. A., WINSTANLEY, C.
(2002). Distribution of type III secretion gene clusters in Burkholderia pseudomallei, B. thailandensis and B. mallei. J Med Microbiol
51: 374-384
[Abstract]
[Full Text]
-
LIU, Y., WANG, D., YAP, E. H., YAP, E. P. H., LEE, M.-A.
(2002). Identification of a novel repetitive DNA element and its use as a molecular marker for strain typing and discrimination of ara- from ara+Burkholderia pseudomallei isolates. J Med Microbiol
51: 76-82
[Abstract]
[Full Text]
-
WINSTANLEY, C., HART, C. A.
(2001). Type III secretion systems and pathogenicity islands. J Med Microbiol
50: 116-126
[Abstract]
[Full Text]